Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis

by Amaral, Teresa , Tabatabai, Ghazaleh , Skardelly, Marco , Klumpp, Bernhard , Zips, Daniel , Tampouri, Ioanna , Keim, Ulrike , Forschner, Andrea , Heinrich, Vanessa , Eigentler, Thomas , Paulsen, Frank , Gepfner-Tuma, Irina , Tatagiba, Marcos , Garbe, Claus

in Brain cancer / Chemotherapy / Clinical trials / Disease control / dominant systemic therapy / Immunotherapy / Medical prognosis / Melanoma / melanoma brain metastases / Metastases / Metastasis / overall survival / Patients / Radiation therapy / Radiosurgery / Skin cancer / stereotactic radiation / Surgery / Survival / Survival analysis / targeted therapy / whole brain irradiation

2019

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis

2019

Confirm

Do you wish to request the book?

Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis

2019

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis

Amaral, Teresa,

Tabatabai, Ghazaleh,

Skardelly, Marco,

Klumpp, Bernhard,

Zips, Daniel,

Tampouri, Ioanna,

Keim, Ulrike,

Forschner, Andrea,

Heinrich, Vanessa,

Eigentler, Thomas,

Paulsen, Frank,

Gepfner-Tuma, Irina,

Tatagiba, Marcos,

Garbe, Claus

2019

Overview

Melanoma brain metastases (MBM) are associated with a dismal prognosis. Few clinical trials evaluated the impact of immunotherapy (IT) and targeted therapy (TT) alone or in combination with surgery and radiotherapy in this population. Retrospective analysis of data from 163 patients diagnosed with MBM between January 2014 and December 2016. Prognostic factors of overall survival were analyzed using Kaplan-Meier survival curves, classification and regression tree and multivariate Cox regression analysis. The median follow-up was 25 months; median overall survival (mOS) for all patients was 7 months. For patients receiving IT, the mOS was 13 months and 7 months for patients receiving TT or chemotherapy (CT). The mOS for patients treated with surgery/radiosurgery in combination with IT, TT and CT was 25, 14 and 11 months, respectively. New systemic therapies, especially IT, improve mOS in patients with MBM, particularly when combined with surgery/radiosurgery upfront.

Share this book

Add to My Shelf

Publisher

Future Medicine Ltd

Subject

/ dominant systemic therapy

/ Immunotherapy

/ Medical prognosis